Antileishmanial activity of the estrogen receptor modulator raloxifene.

BACKGROUND: The treatment of leishmaniasis relies mostly on parenteral drugs with potentially serious adverse effects. Additionally, parasite resistance in the treatment of leishmaniasis has been demonstrated for the majority of drugs available, making the search for more effective and less toxic dr...

Full description

Bibliographic Details
Main Authors: Juliana Q Reimão, Danilo C Miguel, Noemi N Taniwaki, Cristiana T Trinconi, Jenicer K U Yokoyama-Yasunaka, Silvia R B Uliana
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-05-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC4014391?pdf=render

Similar Items